Cartesian Therapeutics, Inc. (RNAC) Operating cash flow 2016–2025
Cartesian Therapeutics, Inc. (RNAC) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$73.9MFY2025 · since FY2016: -$19.8M → -$73.9M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$73.9M | -212.3% |
| FY2024 | -$23.7M | +53.7% |
| FY2023 | -$51.2M | -61.7% |
| FY2022 | -$31.6M | +47.6% |
| FY2021 | -$60.4M | -273.1% |
| FY2020 | $34.9M | +167.8% |
| FY2019 | -$51.4M | +13.1% |
| FY2018 | -$59.2M | -13.7% |
| FY2017 | -$52.0M | -163.3% |
| FY2016 | -$19.8M | — |
Source: SEC XBRL filings · For reference only · Not investment advice